Clinical Trials Update: Sept. 29, 2003
Ulcerative Colitis Genital Herpes Prostate Cancer
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A 6-week research study to evaluate an investigational drug for ulcerative colitis. Volunteers who have been diagnosed with moderately active ulcerative colitis may be eligible. Research sites located throughout the United States.
A research study to test the effectiveness of an approved oral medication for genital herpes. Volunteers 18 or older who have genital herpes with at least four outbreaks in the past year may be eligible. Research site located in Westlake Village, California.
A research study of an investigational medication for prostate cancer. Volunteers 18 or older who have cancer of the prostate that has progressed after androgen deprivation therapy and who have bone disease that is spreading may be eligible. Research site located in Jamaica, New York.
Copyright 2003 CenterWatch. All rights reserved.